Clinical Trials Directory

Trials / Completed

CompletedNCT01923519

Study of Genic Expression Profiles of the Epithelium of the Nose and Bronchi in Healthy and Allergic Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The respiratory epithelium plays a leading role in the development of allergic respiratory disease with barrier function alteration, its repair mechanisms, of anti-viral fight and the ability to induce by itself Th2 responses. The majority of allergic asthmatic patients have reached concomitant ENT: the concept of "one airway, one disease." Access to this material of epithelial study in the different phenotypes of the disease appears to be crucial. Nasal and bronchial epithelial tissues reveal essential differences in particular related to their environment (remodeling less intense and a lower sensitivity to the virus in the nose), but they nevertheless share many common cellular characteristics.

Conditions

Interventions

TypeNameDescription
PROCEDUREbronchofiberscopy

Timeline

Start date
2013-11-29
Primary completion
2016-11-28
Completion
2017-05-07
First posted
2013-08-15
Last updated
2026-03-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01923519. Inclusion in this directory is not an endorsement.